Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Fostair

- PMLiVE

Rigel on the slide as asthma drug falls over

Share plummet after phase II failure of R343

ABPI London offices

ABPI toolkit to help pharma companies disclose trial data

Aims to improve transparency efforts in UK

- PMLiVE

UCB’s Steve Arnold joins ABPI board

Will work to support life sciences in the UK

- PMLiVE

Non-amyloid therapies emerging for Alzheimer’s at AAIC

AAIC meeting hears new clinical data from Lundbeck, Baxter, Chiesi and Takeda

- PMLiVE

ABPI appoints new director of comms

Catherine Meaden was previously head of policy and public affairs at the body

- PMLiVE

England to launch 15 networks for NHS to work with academia

NHS England backs Academic Health Science Networks to spread innovation

ABPI London offices

ABPI: Pharma must sell outcomes, not products

Annual conference told industry must re-establish its social contract with the NHS

ABPI publishes updated guidance on pharmacovigilance and digital media

In a guest blog, the ABPI's Esteban Herrero-Martinez explains what changes to European pharmacovigilance legislation mean for ABPI members

- PMLiVE

Pharmaceutical conference to discuss healthcare in the new NHS

ABPI’s chief executive calls for “bold, provocative ideas” in new UK healthcare landscape

ABPI London offices

Pharma paid UK healthcare professionals £40m in 2012

Payments published as part of ABPI drive towards greater industry transparency

- PMLiVE

Discount convinces NICE to uphold recommendation for Novartis’ Xolair

Asthma drug now also available for children

ABPI London offices

ABPI to tighten up transparency compliance

Hires independent third party to monitor for incidents of non-compliance

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links